30
Participants
Start Date
June 30, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
April 30, 2014
human VWF/FVIII concentrate
intravenous infusion. Dose based on subject's individual invivo-recovery
SHAT Joan Pavel, Sofia
Hemophilia Comprehensive Care Center, Johannesburg
Granda Ospedale Maggiore Policlinico, Milan
UNC-CH Comprehensive Hemophilia Center, Chapel Hill
Ege University, Izmir
ULSS6 Vicenza Ematologia, Vicenza
Indiana Hemophilia and Thrombosis Center, Indianapolis
Azienda Ospedaliero Universitaria Careggi, Florence
Blood Center of Wisconsin, Milwaukee
Louis Turcanu Childrens Emergency Hospital, Timișoara
Sahyadri Specialty Hospital, Pune
Christian Medical College, Vellore
Sultan Quaboos University Hospital, Muscat
Instytut Hematologii i Transfuzjologii, Warsaw
Fundeni Clinical Institute, Bucharest
Lead Sponsor
Octapharma
INDUSTRY